Alexandria’s client tenant has signed a 10-year lease at 499 Illinois Street for approximately 97,700 rentable square feet (RSF), or 45%, of the 219,600 RSF facility, consistent with the Company’s current “initial yield” projections. The client tenant will open a state-of-the-art RD center in Mission Bay focused on the development of next generation products and services, as well as a customer demonstration and training center.

Alexandria’s Mission Bay life science cluster is renowned for its significant talent base – a dense concentration of Nobel Prize winners, scientists, doctoral students, entrepreneurs, venture capitalists, and technologists from first-class client tenants including the University of California, San Francisco (UCSF), California Institute for Quantitative Biosciences (QB3), Bayer AG, Celgene Corporation, Fibrogen, Inc., Nektar Therapeutics, Inc., and blue chip venture capital firms such as Novo Ventures, OrbiMed Advisors, Third Rock Ventures, venBio, and Versant Ventures.

At the heart of Mission Bay, UCSF is leading the Precision Medicine revolution, which aims to integrate genomic, clinical and environmental data into routine clinical practice and improve patient diagnosis and treatments. In recent weeks, Mission Bay has garnered international acclaim with the announcement that two major drug developers – Roche and Bayer AG – have initiated strategic partnerships with QB3. In addition to Roche and Bayer AG, Novartis AG and Pfizer Inc. have also joined the QB3 program. With innovative collaborations pioneered by QB3 as well as UCSF’s intensifying intellectual and capital investment in translational medicine, Mission Bay has become the epicenter of life science innovation, collaboration and translation in the San Francisco Bay Area. The current market demand is very strong for 499 Illinois Street particularly, and Mission Bay more broadly, from multiple market segments including life science, translational clinical uses and the rapidly expanding technology sector.

“We are honored to welcome this exceptional client tenant to the Mission Bay life science ecosystem and 499 Illinois Street for the creation of an iconic RD center,” said Stephen A. Richardson, Chief Operating Officer and Regional Market Director of Alexandria’s San Francisco Bay Area Cluster. “This Company is a world-class organization, and we look forward to integrating its team into the highly innovative and collaborative Mission Bay life science community.”

The client tenant’s Mission Bay RD center will feature unique and creative amenity spaces, including a high-quality cafe, an activated bay front plaza with distinct recreational areas, and a cutting-edge fitness center. This iconic campus environment, ideally situated within the highly innovative and urban Mission Bay life science ecosystem, will provide the Company with a unique advantage in recruitment and retention, as well as driving productivity for this world-class organization.

About Alexandria Real Estate Equities, Inc.    
Alexandria Real Estate Equities, Inc. (NYSE: ARE), a self-administered and self-managed real estate investment trust (REIT), is the leading and largest investment-grade REIT focused principally on owning, operating, redeveloping, developing, and acquiring high-quality, sustainable real estate for the broad and diverse life science industry. Founded in 1994, Alexandria was the first REIT to identify and pursue a primary focus on the laboratory niche and has since had the first-mover advantage in every core life science cluster location including Greater Boston, the San Francisco Bay Area, San Diego, New York City, Seattle, Suburban Washington, D.C., and Research Triangle Park. Alexandria’s high-credit client tenants span the life science industry, including renowned academic medical research centers, multinational pharmaceutical companies, public and private biotechnology entities, U.S. government research agencies, medical device companies, industrial biotechnology companies, venture capitalists, and life science product and service companies. Forty-six percent of Alexandria’s total annualized base rent is generated from investment-grade client tenants. As the recognized real estate partner of the life science industry, Alexandria has a superior track record in driving client tenant productivity, collaboration, and innovation through its CBD locations adjacent to leading academic medical research centers, best-in-class laboratory/office space, unparalleled life science real estate expertise and services, and longstanding and expansive network in the life science community, which we believe result in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For more information, please visit www.are.com.

This press release contains forward-looking statements within the meaning of the federal securities laws.  Actual results may differ materially from those projected in the forward-looking statements. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements is contained in our Annual Report on Form 10-K and our other periodic reports filed with the Securities and Exchange Commission.

SOURCE Alexandria Real Estate Equities, Inc.

Article source: http://www.fiercebiotech.com/press-releases/alexandrias-499-illinois-street-mission-bay-san-francisco-signs-anchor-9770-0

Kilroy Realty Corporation (NYSE:KRC) went up 0.42%, to close at $40.17 and its overall traded volume was 698,530.00 shares in the last trading session. KRC opened at $40.12 and is trading within the range of $39.81-$40.29. The 52-week range of the stock is $27.21 – $42.41. KRC’s market capitalization is $2.35B and it has 58.46M outstanding shares.Kilroy Realty Corporationis a self-administered real estate investment trust (REIT) engaged in office and industrial submarkets along the West Coast. The Company owns, develops, acquires and manages primarily Class A real estate assets in the coastal regions of Los Angeles, Orange County, San Diego, greater Seattle and the San Francisco Bay Area. As of December 31, 2010, its stabilized portfolio consisted of the office buildings (the Office Properties) and industrial buildings (the Industrial Properties). As of December 31, 2010, all but one of its properties was located in California. The Company owns its interests in all of its Office Properties and Industrial Properties through the Kilroy Realty, L.P. (Operating Partnership) and Kilroy Realty Finance Partnership, L.P. (the Finance Partnership). During the year ended December 31, 2010, it acquired 2385 Northside Drive San Diego, CA, 303 Second Street San Francisco, CA and 999 Town Country Orange, CA.

Kayne Anderson Energy Total Return Fund (NYSE:KYE) percentage change dropped -0.91%, to close at $28.45 and its overall traded volume was 94,752.00 shares in the last trading session. KYE opened at $28.67 and is trading within the range of $28.37-$28.77. The stock has a 52 week range of $20.70 – $31.99. At current market price, the market capitalization of the company stands at $981.30M and it has 34.49M outstanding shares.Kayne Anderson Energy Total Return Fund, Inc. (the Fund) is a non-diversified, closed-end fund. The Fund’s investment objective is to obtain a high total return with an emphasis on current income by investing primarily in securities of companies engaged in the energy industry. The Fund’s investments include master limited partnerships (MLPs) and limited liability companies taxed as partnerships MLP affiliates, the United States and Canadian royalty trusts and income trusts (collectively, royalty trusts), marine transportation companies, and other companies that derive at least 50% of their revenues from operating assets used in, or providing energy-related services for, the exploration, development, production, gathering, transportation, processing, storing, refining, distribution, mining or marketing of natural gas, natural gas liquids, crude oil, refined petroleum products or coal. The Fund’s investment advisor is KA Fund Advisors, LLC.

Lydall, Inc. (NYSE:LDL) fell -2.76%, to close at $10.55 and its overall traded volume was 48,910.00 shares in the last trading session. LDL opened at $10.88 and is trading within the range of $10.54-$11.18. The 52-week range of the stock is $6.51 – $11.39. The market capitalization of the company stands at $180.98M and it has 17.15M outstanding shares.Lydall, Inc. (Lydall) together with its subsidiaries, designs and manufactures specialty engineered filtration media, industrial thermal insulating solutions, automotive thermal and acoustical barriers, temperature-control equipment, medical filtration media and devices, and biopharmaceutical processing components for demanding thermal/acoustical, filtration/separation and bio/medical applications. The Company operates in two segments: Performance Materials and Thermal/Acoustical. The Thermal/Acoustical segment includes the operations of Lydall’s automotive businesses. The Performance Materials segment includes the operations of the filtration and industrial thermal insulation businesses. All other businesses are included in other products and services (OPS). In July 2010, Lydall, Inc. sold its electrical papers product line targeted for the transformer industry, and licensed certain related manufacturing technologies, to WEIDMANN Electrical Technology, Inc.

Alliant Energy Corporation (NYSE:LNT) slid -0.61%, to close at $40.74 and its overall traded volume was 808,366.00 shares in the last trading session. LNT shares were trading within the range of $40.49-$41.14 while its opening price was $41.12. The 52-week range of the stock is $30.40 – $41.14. The market capitalization of the company stands at $4.52B and it has 110.94M outstanding shares.Alliant Energy Corporation (Alliant Energy) operates as a regulated investor-owned public utility holding company. The Company focuses to provide regulated electricity and natural gas service to approximately one million electric and approximately 412,000 natural gas customers in the Midwest through its two public utility subsidiaries. The subsidiaries of the Company include Iowa Railway and Light Corporation (IPL), Eastern Wisconsin Electric Company (WPL), Alliant Energy Resources, LLC (Resources) and Alliant Energy Corporate Services, Inc. (Corporate Services). IPL is a public utility engaged principally in the generation and distribution of electric energy and the distribution and transportation of natural gas in selective markets in Iowa and southern Minnesota. WPL is a public utility engaged principally in the generation and distribution of electric energy and the distribution and transportation of natural gas in selective markets in southern and central Wisconsin.

MFA Financial, Inc. (NYSE:MFA) percentage change fell -0.73%, to close at $8.16 and its overall traded volume was 2.14M shares in the last trading session. MFA opened at $8.24 and is trading within the range of $8.15-$8.24. The stock has a 52 week low of $6.79 and 52 week high of $8.64. The market capitalization of the company stands at $2.91B and it has 356.06M outstanding shares.MFA Financial, Inc. is engaged in the business of investing, on a leveraged basis, in residential Agency and Non-Agency mortgage-backed securities (MBS). It generates net income for distribution to its stockholders resulting from the difference between the interest and other income it earns on its investments and the interest expense it pays on the borrowings, which it uses to finance its leveraged investments and its operating costs.

Posted by Tom Walsh
on May 16 2011. Filed under Stocks.
You can follow any responses to this entry through the RSS 2.0.
You can leave a response or trackback to this entry

Article source: http://acovi.com/pf-triple-top-breakout-krc-kye-ldl-lnt-mfa/225173/